PAST WEBINARS
ADME and Bioanalytical Strategies for ADCs: Challenges, Emerging Technologies, and Regulatory Considerations
Antibody-drug conjugates (ADCs) are transforming cancer treatment, but their development brings unique challenges in the DMPK field, including ADME, bioanalysis, and regulatory registration. This webinar explores integrated DMPK and bioanalytical strategies for ADC discovery and development, grounded in recent analytical advances, global guidelines, and real-world experience.